Expertise in
1
conditions

Min H. Tao

State Key Laboratory Of Water Disaster Prevention, 
Nanjing, CN 
Expertise in
1
conditions
State Key Laboratory Of Water Disaster Prevention, 
Nanjing, CN 

Overview

Min Tao practices practicing medicine in Nanjing, China.

Tao is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Necrosis, Secondary Peritonitis, and Hepato-Pancreato-Biliary Surgery.

They are actively involved in clinical research, co-authoring 260 peer reviewed articles and participating in 2 clinical trials.

Locations

State Key Laboratory Of Water Disaster Prevention, Nanjing, 210024, China
Other Locations
Huangshi, 435003, China
150 Jimo Road, Shanghai, 200120, China
Suzhou, China
Tianjin, 300072, China
Wuxi, China
No. 548 Binwen Road, Binjiang District, Hangzhou, 310053, China
Hefei, 230601, China
Beijing Key Laboratory Of Cell And Gene Therapy For Solid Tumor, Key Laboratory Of Carcinogenesis And Translational Research, Beijing, China
Wuhan, 430071, China
Wenzhou, China
Wuhu, 241003, China
Neijiang, China
Chongqing, 400038, China
215006, China
Bengbu, China
Dalian, 116622, China
Guangzhou, China
Tongji, China
Bengbu, 233004, China
Dalian, China
Changzhou, 213003, China
Taizhou, 318020, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
A Phase 3, Open-Label, Multicenter, Randomized Study to Investigate the Efficacy and Safety of Tislelizumab (BGB-A317) (Anti-PD1 Antibody) Combined With Platinum-Pemetrexed Versus Platinum-Pemetrexed Alone as First-line Treatment for Patients With Stage IIIB or IV Non-Squamous Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug
Study Drugs: Tislelizumab+Cisplatin or Carboplatin+Pemetrexed, Cisplatin or Carboplatin+Pemetrexed
Study Phase: Phase 3
Comparison of Efficacy and Safety of Icaritin Versus Sorafenib in First-line Treatment of PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects: a Multicenter, Randomized, Opened Phase III Clinical Trial
Comparison of Efficacy and Safety of Icaritin Versus Sorafenib in First-line Treatment of PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects: a Multicenter, Randomized, Opened Phase III Clinical Trial
Enrollment Status: Terminated
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: Icaritin, Sorafenib Tosylate Tablets
Study Phase: Phase 3
View 1 Less Clinical Trial

260 Total Publications

Acupoint Plaster Application Combined with Omalizumab for Severe Allergic Asthma: A Randomized Controlled Trial.
Acupoint Plaster Application Combined with Omalizumab for Severe Allergic Asthma: A Randomized Controlled Trial.
Journal: Journal of visualized experiments : JoVE
Published: August 22, 2026

Frequently Asked Questions about Min H. Tao

Is Min H. Tao a top-rated expert for Stomach Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Min H. Tao is classified as an Advanced expert for Stomach Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Min H. Tao participate in research or clinical trials?

Yes. Min H. Tao has published 260 articles and abstracts on conditions like Stomach Cancer. You can view a list of Min H. Tao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tao's expertise for a condition
ConditionClose
      View All 45 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile